IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Thyrocare Technologies IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ 479.21 Cr. The company is based in Mumbai and caters to Healthcare sector. Edelweiss Financial Services , ICICI Securities , Jm Financial are the merchant bankers of Thyrocare Technologies IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 30th December 2015.
Thyrocare Technologies IPO open date is 27th April 2016 and close date is 29th April 2016. IPO Allotment Date is 30th November -0001 and Listing date is 9th May 2016.
IPO
Size:
₹ 479.21 Cr.
Avg IPO Size (Sector Based)
: ₹
978.00 cr.
Sector: Healthcare
IPO so far:
28
Merchant Banker:
Edelweiss Financial
IPO by BRLM so far:
70
City:
Mumbai
IPO so far:
189
Revenue (annualised):
₹
240.63
cr. 
PE
Ratio:
45.00x
Average Sector PE Ratio: 27.92x
Thyrocare Technologies IPO size is ₹ 479.21 Cr. with IPO price of ₹ 446.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Edelweiss Financial Services Limited is the book-running lead manager of the Thyrocare Technologies IPO. Link Intime India Private Limited is the Registrar for Thyrocare Technologies IPO.
Thyrocare Technologies IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Thyrocare Technologies IPO, based in Mumbai, operates in the Healthcare sector with a focus on diagnostic chains and conducts an array of medical diagnostic tests and profiles of tests that center. The company is launching its MainBoard IPO on the BSE,NSE exchange, using the Book Building Issue method. Thyrocare Technologies IPO size is ₹ 479.21 Cr. with fresh issue size of ₹ 479 and Offer for sale being ₹ Nil
The IPO allotment date for Thyrocare Technologies IPO is expected to be 30th November -0001, after the finalization of basis of allotment. Investors can check Thyrocare Technologies IPO allotment status on the registrars website, Link Intime India Private Limited . Thyrocare Technologies IPO refund dates are 30th November -0001.
Thyrocare Technologies IPO is expected to be listed on 9th May 2016.
The upper price band for the Thyrocare Technologies IPO is set at ₹ 446.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Thyrocare Technologies IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Thyrocare Technologies IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 29th April 2016. After submission, funds are blocked until the basis of allotment of Thyrocare Technologies IPO is finalised.
The merchant banker for Thyrocare Technologies IPO is Edelweiss Financial Services Limited , ICICI Securities Limited , Jm Financial Limited . Edelweiss Financial Services Limited , ICICI Securities Limited , Jm Financial Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Thyrocare Technologies IPO RHP for further details.
The registrar for Thyrocare Technologies IPO is Link Intime India Private Limited . Investors can go to Link Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Thyrocare Technologies IPO through their official website or helpline.
Thyrocare Technologies IPO was subscribed 73.55 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 479.21 Cr.
Avg IPO Size (Sector Based)
:
₹ 978.00 Cr.
Sector: Healthcare
IPO so far:
28
Merchant Banker:
Edelweiss Financial
IPO by BRLM so far:
70
City:
Mumbai
IPO so far:
189
Revenue (annualised):
₹ 234.55 cr.
PE
Ratio:
45.00x
Average Sector PE Ratio: 27.92x
Thyrocare Technologies IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Thyrocare Technologies Financial Review Page
Merchant Banker(s) of Thyrocare Technologies IPO: Edelweiss Financial Services Limited , ICICI Securities Limited , Jm Financial Limited
Thyrocare Technologies IPO subscription was 73.55 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Thyrocare Technologies IPO listed at a listing price of 618.10 against the offer price of 446.00.
The current market price of Thyrocare Technologies is 1184.35.
Why Us?
